# Effect of Autologous Blood Patch Injection Versus BioSentry Hydrogel Tract Plug in the Reduction of Pneumothorax Risk Following Lung Biopsy Procedures

> **NCT02224924** · PHASE3 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 454 (actual)

## Conditions studied

- Lung Biopsy

## Interventions

- **OTHER:** ABPI
- **DEVICE:** BioSentry (formerly known as Bio-Seal) hydrogel Tract Plug

## Key facts

- **NCT ID:** NCT02224924
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-21
- **Primary completion:** 2023-01-11
- **Final completion:** 2023-01-11
- **Target enrollment:** 454 (ACTUAL)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02224924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02224924, "Effect of Autologous Blood Patch Injection Versus BioSentry Hydrogel Tract Plug in the Reduction of Pneumothorax Risk Following Lung Biopsy Procedures". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02224924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*